首页 › 基金 › Parkman Healthcare Partners LLC › ALNY
Parkman Healthcare Partners LLC 对 ALNY 的持仓历史
ALNYLAM PHARMACEUTICALS INC · 医疗保健
Parkman Healthcare Partners LLC 在 Q3 2026 的 13F 申报中披露持有 ALNY(ALNYLAM PHARMACEUTICALS INC)35,159 股,市值约 US$8.7M,约占其申报组合的 0.78%,在其申报持仓中市值排名第 50 位。 Parkman Healthcare Partners LLC 最近 9 个申报季度中有 9 个季度披露了 ALNY 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Parkman Healthcare Partners LLC 对 ALNY 的持仓演变
Parkman Healthcare Partners LLC 于 Q3 2024 首次披露 ALNY 持仓:25,485 股(约 US$7.0M)。 该持仓在 Q3 2025 达到峰值 87,690 股,市值约 US$40.0M。 在 9 次申报中,Parkman Healthcare Partners LLC 4 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 35,159 股、市值约 US$8.7M,环比减持 -15,513 股。。 持仓曾出现大幅变动:Q4 2024 增持约 52% (随后一个季度股价上涨 15%)、Q1 2025 增持约 78% (随后一个季度股价上涨 20%)、Q2 2026 增持约 88% (随后一个季度股价下跌 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 25.48K | $7.01M | 新进 |
| Q4 2024 | 38.67K | $9.10M | 增持 |
| Q1 2025 | 68.94K | $18.61M | 增持 |
| Q2 2025 | 92.34K | $30.11M | 增持 |
| Q3 2025 | 87.69K | $39.99M | 减持 |
| Q4 2025 | 47.70K | $18.97M | 减持 |
| Q1 2026 | 26.92K | $8.91M | 减持 |
| Q2 2026 | 50.67K | $15.25M | 增持 |
| Q3 2026 | 35.16K | $8.68M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ALNY 与 13F 数据
ALNY(ALNYLAM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 ALNY,申报仓位最大的包括:T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford (US$1.36B), Orbis Allan Gray Ltd (US$597.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ALNY 的基金
- T. Rowe Price Investment Management, Inc. 5.64M 股 · $1.70B · Q2 2026
- Baillie Gifford 5.49M 股 · $1.36B · Q3 2026
- Orbis Allan Gray Ltd 2.42M 股 · $597.40M · Q3 2026
- TWO SIGMA ADVISERS, LP 1.13M 股 · $450.36M · Q4 2025
更多关于 Parkman Healthcare Partners LLC
常见问题
How long has Parkman Healthcare Partners LLC held ALNY?
Parkman Healthcare Partners LLC has disclosed ALNY holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Parkman Healthcare Partners LLC's current position in ALNY?
As of Q3 2026, Parkman Healthcare Partners LLC holds 35.16K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $8.68M, representing 0.78% of its reported portfolio and ranking #50.
Has Parkman Healthcare Partners LLC been buying or selling ALNY?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in ALNY. The position peaked in Q3 2025 at 87.69K shares.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford, Orbis Allan Gray Ltd, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.